1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. PDGFR
  4. PDGFR Inhibitors

PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PDGFR Inhibitors
Product Name PDGFR PDGFRβ PDGFRα Purity
Lenvatinib  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.87%
Nintedanib  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.97%
Regorafenib  
PDGFRβ, IC50: 22 nM
  ≥99.0%
Sunitinib  
PDGFRβ, IC50: 2 nM
  ≥98.0%
(Z)-Orantinib  
PDGFRβ, IC50: 0.008 μM
  99.02%
TG 100572  
PDGFRβ, IC50: 13 nM
 
Ponatinib    
PDGFRα, IC50: 1.1 nM
99.13%
Axitinib  
PDGFRβ, IC50: 1.6 nM
  99.94%
Pazopanib  
PDGFRβ, IC50: 84 nM
  99.68%
SU 5402  
PDGFRβ, IC50: 510 nM
  99.39%
Crenolanib  
PDGFRβ, Kd: 3.2 nM
PDGFRα, Kd: 2.1 nM
99.67%
Sunitinib Malate  
PDGFRβ, IC50: 2 nM
  ≥99.0%
Ripretinib    
PDGFRA
98.90%
Nintedanib esylate  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.93%
Cediranib  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
≥98.0%
CP-673451  
PDGFRβ, IC50: 1 nM
PDGFRα, IC50: 10 nM
99.65%
Dovitinib  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
97.18%
Pazopanib Hydrochloride  
PDGFRβ, IC50: 84 nM
  99.84%
Amuvatinib    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
98.07%
Linifanib  
PDGFRβ, IC50: 66 nM
  99.72%
Regorafenib Hydrochloride  
PDGFRβ, IC50: 22 nM
  ≥98.0%
Lenvatinib mesylate  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.86%
CHIR-124
PDGFR, IC50: 6.6 nM
    ≥95.0%
ENMD-2076    
PDGFRα, IC50: 56.4 nM
99.12%
Ilorasertib hydrochloride  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
98.91%
PP121
PDGFR, IC50: 2 nM
    99.08%
Tandutinib
PDGFR, IC50: 0.2 μM
    99.48%
Telatinib    
PDGFRα, IC50: 15 nM
98.72%
SU14813  
PDGFRβ, IC50: 4 nM
  98.90%
TAK-593  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 4.3 nM
PDGFRαV561D, IC50: 1 nM
99.62%
TG 100801  
PDGFRβ, IC50: 13 nM
  ≥95.0%
Dovitinib lactate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
99.96%
Orantinib  
PDGFRβ, Ki: 8 nM
  98.80%
Cediranib maleate  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.74%
Regorafenib monohydrate  
PDGFRβ, IC50: 22 nM
  99.96%
Toceranib phosphate  
PDGFRβ, Ki: 5 nM
  98.02%
PP58
PDGFR
    99.48%
JI-101  
PDGFRβ
  99.95%
JNJ-10198409  
PDGFRβ, IC50: 4.2 nM
PDGFRα, IC50: 45 nM
≥99.0%
Toceranib  
PDGFRβ, Ki: 5 nM
  96.25%
ENMD-2076 Tartrate    
PDGFRα, IC50: 56.4 nM
98.87%
Tandutinib hydrochloride
PDGFR, IC50: 0.2 μM
    98.84%
AC710  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM
99.89%
Methylnissolin
PDGFR, IC50: 10 μM
    99.53%
Tyrosine kinase-IN-1    
PDGFRα, IC50: 4 nM
99.47%
SU14813 maleate  
PDGFRβ, IC50: 4 nM
  99.95%
AZD2932  
PDGFRβ, IC50: 4 nM
  ≥98.0%
SU16f
PDGFR2, IC50: 140 nM
PDGFR1, IC50: 2.29 μM
PDGFRβ, IC50: 10 nM
  ≥99.0%
PDGFRα kinase inhibitor 1  
PDGFRβ, IC50: 6115 nM
PDGFRα, IC50: 132 nM
99.90%
Tyrphostin AG1433  
PDGFRβ, IC50: 5 μM
  99.20%
NVP-ACC789  
PDGFR-β, IC50: 1.4 μM
  99.94%
Tyrphostin AG1296  
PDGFRβ
PDGFRα
99.25%
SU4312
PDGFR
    98.19%
Ilorasertib  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
≥98.0%
Dovitinib lactate hydrate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
GZD856  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
Telatinib mesylate    
PDGFRα, IC50: 15 nM
Amuvatinib hydrochloride    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
GZD856 formic  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
98.06%
KG5  
PDGFRβ, Kd: 520 nM
PDGFRα, Kd: 300 nM
PD-089828  
PDGFR-β, IC50: 1.76 μM
PDGFR-β, Ki: 2.38 μM
 
Multi-kinase inhibitor 1
PDGFR
   
PD-161570
PDGFR, IC50: 310 nM
PDGFRβ, IC50: 262 nM
 
Hypothemycin  
PDGFRβ, Ki: 900 nM
PDGFRα, Ki: 1.5 μM
HG-7-85-01    
PDGFRα, IC50: 440 nM
Sunitinib D10  
PDGFRβ, IC50: 2 nM
 
Ponatinib D8    
PDGFRα, IC50: 1.1 nM
TG 100801 Hydrochloride  
PDGFRβ, IC50: 13 nM